Yuxiang Gao

Dr. Yuxiang Gao


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in Medicine
Verified
Journal Article
Open access
QNQingmei Niu
Qingmei Niu
JZJunkang Zhao
Junkang Zhao
YJYatian Jia
Yatian Jia
SDShuo Ding
Shuo Ding
YGYuxiang Gao
Yuxiang Gao
QZQian Zhang
Qian Zhang
This study examines the association between the aggregate index of systemic inflammation (AISI) and mortality among individuals with abdominal obesity, aiming to provide a scientific basis for accurate identification of high-risk individuals and the implementation of early interventions. This study utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999–2016 to include adults with abdominal obesity. The AISI was calculated as (neutrophil count × platelet count × monocyte count)/lymphocyte count. Participants were linked to the National Death Index to determine vital status, with mortality follow-up extending through December 31, 2019. The association between the AISI and mortality risk in individuals with abdominal obesity was examined through Kaplan–Meier survival analysis, weighted Cox proportional hazards regression, subgroup stratification, and restricted cubic spline modeling. This cohort study enrolled 15,839 adult participants with abdominal obesity. During a median follow-up of 119 months, 2223 deaths were recorded. Kaplan–Meier survival analysis showed that elevated levels of the AISI were significantly associated with reduced survival probability. After comprehensive adjustment for multiple potential confounders, multivariate Cox proportional hazards regression revealed a significant positive association between AISI levels and all-cause mortality risk in individuals with abdominal obesity. When AISI was treated as a continuous variable, each 1-unit increase was associated with a 1% higher risk of death (fully adjusted HR = 1.01, 95% CI: 1.01–1.01, P < .001). When dichotomized at the median, the high AISI group exhibited a 16% increased risk of mortality compared to the low AISI group (fully adjusted HR = 1.16, 95% CI: 1.04–1.30, P = .010). Restricted cubic spline analysis confirmed a statistically significant linear relationship ( P for overall < .001; P for nonlinearity = .192). Subgroup analyses indicated heterogeneity in this association across marital status subgroups (interaction P = .017). This study demonstrates that elevated AISI levels are associated with increased mortality risk among individuals with abdominal obesity. These findings underscore the value of AISI as a prognostic indicator for mortality in this at-risk population. The integration of AISI into clinical inflammatory assessment frameworks may facilitate the establishment of dynamic surveillance strategies for identifying and monitoring high-risk individuals.

16 October 2026 in Medicine
Verified
Journal Article
Open access
YXYangyu Xu
Yangyu Xu
HZHong Zhao
Hong Zhao
YGYuxiang Gao
Yuxiang Gao
JHJiannan Han
Jiannan Han
ZWZewen Wu
Zewen Wu
JZJunkang Zhao
Junkang Zhao
Cardiovascular disease (CVD) is a major cause of excess mortality among patients with rheumatoid arthritis (RA). Conventional risk assessment may not fully capture the metabolic abnormalities and physiological vulnerability associated with RA. We investigated whether the triglyceride-glucose–frailty index (TyG-FI), which combines a surrogate marker of insulin resistance with accumulated health deficits, was associated with prevalent CVD and cardiovascular mortality among adults with RA. We analyzed 1090 adults with self-reported RA from 10 cycles of the National Health and Nutrition Examination Survey conducted between 1999 and 2018. TyG-FI was calculated as the product of the triglyceride-glucose index and a 49-item deficit-accumulation frailty index. Multivariable logistic regression was used to examine the association with prevalent CVD, whereas Cox proportional hazards regression was used to examine cardiovascular mortality. Restricted cubic splines, subgroup analyses, sensitivity analyses, and discrimination analyses were conducted as secondary analyses. In the fully adjusted models, each 1-unit higher TyG-FI was associated with higher odds of prevalent CVD (odds ratio, 4.50; 95% confidence interval, 3.20–6.33) and a higher hazard of cardiovascular mortality (hazard ratio, 1.77; 95% confidence interval, 1.16–2.70). The reported areas under the receiver operating characteristic curve were 0.80 for prevalent CVD and 0.81 for cardiovascular mortality in models incorporating TyG-FI, compared with 0.73 and 0.80, respectively, in models incorporating TyG. An exploratory subgroup analysis suggested a stronger association between TyG-FI and prevalent CVD among participants aged ≤65 years ( P for interaction = .044). Higher TyG-FI was associated with prevalent CVD and cardiovascular mortality among US adults with self-reported RA. TyG-FI may capture complementary metabolic and frailty-related information; however, its incremental predictive value, calibration, clinical utility, and external validity require further evaluation before clinical implementation.